Logo image of ASTH

ASTRANA HEALTH INC (ASTH) Stock Price, Quote, News and Overview

NASDAQ:ASTH - Nasdaq - US03763A2078 - Common Stock - Currency: USD

28.08  +6.62 (+30.85%)

After market: 27.9 -0.18 (-0.64%)

ASTH Quote, Performance and Key Statistics

ASTRANA HEALTH INC

NASDAQ:ASTH (8/8/2025, 8:19:45 PM)

After market: 27.9 -0.18 (-0.64%)

28.08

+6.62 (+30.85%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services
Statistics
52 Week High63.2
52 Week Low21.2
Market Cap1.40B
Shares49.93M
Float38.91M
Yearly Dividend0.09
Dividend YieldN/A
PE55.06
Fwd PE16.49
Earnings (Next)11-05 2025-11-05/amc
IPO04-09 1999-04-09


ASTH short term performance overview.The bars show the price performance of ASTH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 20 -20 30

ASTH long term performance overview.The bars show the price performance of ASTH in the last 1, 2 and 3 years. 1 year 2 years 3 years -10 -20 -30 -40

The current stock price of ASTH is 28.08 USD. In the past month the price increased by 12.77%. In the past year, price decreased by -41.39%.

ASTRANA HEALTH INC / ASTH Daily stock chart

ASTH Competitors/Peers

The largest stocks on the US markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
CVS CVS HEALTH CORP 10.34 82.91B
CI THE CIGNA GROUP 9.79 73.44B
LH LABCORP HOLDINGS INC 17.56 22.04B
DGX QUEST DIAGNOSTICS INC 18.71 19.79B
FMS FRESENIUS MEDICAL CARE-ADR 13.75 14.12B
BTSGU BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 98.55 12.86B
HIMS HIMS & HERS HEALTH INC 64.93 11.63B
DVA DAVITA INC 13.36 9.78B
GH GUARDANT HEALTH INC N/A 6.72B
CHE CHEMED CORP 19.46 6.37B
OPCH OPTION CARE HEALTH INC 20.89 4.62B
CRVL CORVEL CORP 47.36 4.43B

About ASTH

Company Profile

ASTH logo image Astrana Health, Inc. is a physician-centric, technology-powered, risk-bearing healthcare management company. The company is headquartered in Alhambra, California and currently employs 1,900 full-time employees. The firm provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The firm's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. The company supports more than 20,000 providers.

Company Info

ASTRANA HEALTH INC

1668 S. Garfield Avenue, 2Nd Floor

Alhambra CALIFORNIA US

Employees: 1900

ASTH Company Website

ASTH Investor Relations

Phone: 16262820288

ASTRANA HEALTH INC / ASTH FAQ

What is the stock price of ASTRANA HEALTH INC today?

The current stock price of ASTH is 28.08 USD. The price increased by 30.85% in the last trading session.


What is the ticker symbol for ASTRANA HEALTH INC stock?

The exchange symbol of ASTRANA HEALTH INC is ASTH and it is listed on the Nasdaq exchange.


On which exchange is ASTH stock listed?

ASTH stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ASTRANA HEALTH INC stock?

17 analysts have analysed ASTH and the average price target is 48.39 USD. This implies a price increase of 72.34% is expected in the next year compared to the current price of 28.08. Check the ASTRANA HEALTH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ASTRANA HEALTH INC worth?

ASTRANA HEALTH INC (ASTH) has a market capitalization of 1.40B USD. This makes ASTH a Small Cap stock.


How many employees does ASTRANA HEALTH INC have?

ASTRANA HEALTH INC (ASTH) currently has 1900 employees.


Is ASTRANA HEALTH INC (ASTH) expected to grow?

The Revenue of ASTRANA HEALTH INC (ASTH) is expected to grow by 46.79% in the next year. Check the estimates tab for more information on the ASTH EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy ASTRANA HEALTH INC (ASTH) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ASTRANA HEALTH INC (ASTH) stock pay dividends?

ASTH does not pay a dividend.


When does ASTRANA HEALTH INC (ASTH) report earnings?

ASTRANA HEALTH INC (ASTH) will report earnings on 2025-11-05, after the market close.


What is the Price/Earnings (PE) ratio of ASTRANA HEALTH INC (ASTH)?

The PE ratio for ASTRANA HEALTH INC (ASTH) is 55.06. This is based on the reported non-GAAP earnings per share of 0.51 and the current share price of 28.08 USD. Check the full fundamental report for a full analysis of the valuation metrics for ASTH.


What is the Short Interest ratio of ASTRANA HEALTH INC (ASTH) stock?

The outstanding short interest for ASTRANA HEALTH INC (ASTH) is 3.94% of its float. Check the ownership tab for more information on the ASTH short interest.


ASTH Technical Analysis

ChartMill assigns a technical rating of 3 / 10 to ASTH. When comparing the yearly performance of all stocks, ASTH is a bad performer in the overall market: 90.53% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ASTH Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to ASTH. Both the profitability and the financial health of ASTH get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ASTH Financial Highlights

Over the last trailing twelve months ASTH reported a non-GAAP Earnings per Share(EPS) of 0.51. The EPS decreased by -64.58% compared to the year before.


Industry RankSector Rank
PM (TTM) 1.56%
ROA 2.63%
ROE 4.7%
Debt/Equity 0.54
Chartmill High Growth Momentum
EPS Q2Q%-52.5%
Sales Q2Q%34.66%
EPS 1Y (TTM)-64.58%
Revenue 1Y (TTM)46.72%

ASTH Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to ASTH. The Buy consensus is the average rating of analysts ratings from 17 analysts.

For the next year, analysts expect an EPS growth of 36.88% and a revenue growth 46.79% for ASTH


Ownership
Inst Owners53.66%
Ins Owners9.71%
Short Float %3.94%
Short Ratio5.65
Analysts
Analysts83.53
Price Target48.39 (72.33%)
EPS Next Y36.88%
Revenue Next Year46.79%